Fulgent Genetics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QNov. 5, 2026, 4:09 p.m. ETView on SEC.gov
8-KNov. 5, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedFulgent Genetics Q3 2026 revenue of $90.4 million beats $86.3 million consensus; GAAP loss $(0.48) per share and non-GAAP loss $(0.09) both beat $(0.65) estimate; annual revenue guidance held at $330-$340 million and non-GAAP loss outlook improved
4Oct. 28, 2026, 4:18 p.m. ETView on SEC.gov
4Oct. 28, 2026, 4:18 p.m. ETView on SEC.gov
4Oct. 28, 2026, 4:18 p.m. ETView on SEC.gov
4Sept. 3, 2026, 7:47 p.m. ETView on SEC.gov
4Sept. 3, 2026, 7:47 p.m. ETView on SEC.gov
4Sept. 3, 2026, 7:47 p.m. ETView on SEC.gov
4Sept. 3, 2026, 7:48 p.m. ETView on SEC.gov
4Aug. 28, 2026, 6:06 p.m. ETView on SEC.gov
4Aug. 28, 2026, 6:05 p.m. ETView on SEC.gov
4Aug. 28, 2026, 6:06 p.m. ETView on SEC.gov
4Aug. 28, 2026, 6:06 p.m. ETView on SEC.gov
10-QJuly 30, 2026, 4:13 p.m. ETView on SEC.gov
8-KJuly 30, 2026, 4:09 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
4July 28, 2026, 4:32 p.m. ETView on SEC.gov
4July 28, 2026, 4:32 p.m. ETView on SEC.gov
4July 28, 2026, 4:32 p.m. ETView on SEC.gov